ÂÜÀòÂÒÂ×

Kim has 30 years of experience in accounting and finance, including 25 years in the field of healthcare diagnostic products and services. She is an operations and commercially focused leader who brings a wealth of experience in scaling organizations that bring new technology and services to market.

Prior to joining BrainScope, Kim served as the Chief Financial Officer of private equity-backed Prelude Fertility, a comprehensive fertility services company. During her time there, she led the successful integration of finance and billing operations for multiple acquisitions, establishing Prelude as the fastest growing and largest network of fertility clinics in the country.

Before Prelude, Kim spent five years as the Chief Financial Officer of Boston Heart Diagnostics, a venture-backed CVD diagnostic services start-up. At Boston Heart, Kim was responsible for establishing and scaling all aspects of the company’s financial operations, revenue cycle, commercial support, and HR functions through the successful sale of the company to Eurofins Scientific SE.

Prior to Boston Heart, Kim was the VP Finance at Ipsogen Inc., the US commercial division of French Biotech, Ipsogen S.A., a blood and breast cancer molecular diagnostic product and services company. During her time at Ipsogen, Kim established the Finance function and was responsible for all aspects of Finance and HR operations, and supported the M&A that resulted in the successful sale of the company to Qiagen.

Earlier in her career, Kim was a senior auditor at Ernst & Young LLP, held both accounting and analyst roles at American Cyanamid Company, an international agricultural, chemical, and pharmaceutical conglomerate, and had a 14-year tenure with Quest Diagnostics, a laboratory services company, where she held various roles of increasing responsibility in both Finance and Marketing.